Results 11 to 20 of about 4,293 (240)

Calcinosis cutis of the lower legs - hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation. [PDF]

J Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 9, Page 1144-1146, September 2025.
Ranzinger D, Schaefer T, Schauer F, Eyerich K, Pilz AC.   +4 more
europepmc   +4 more sources

Avid 18F-FDG Uptake in Idiopathic Tumoral Calcinosis Mimicking Lymph Node Metastasis [PDF]

Diagnostics, 2017
Tumoral calcinosis is a benign condition characterized by periarticular calcified lesions that is frequently observed in patients with chronic renal failure. Tumoral calcinosis often presents with subcutaneous masses and joint swelling. We present a case
Jesper Strandberg, Helle D. Zacho
doaj   +4 more sources

The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23

JCRPE, 2022
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder. Topical sodium thiosulfate (STS) and acetazolamide can be a safe and effective treatment for patients who do not respond to conventional therapy for ectopic ...
Hakan Döneray, Ayşe Özden, Kadri Gürbüz   +2 more
doaj   +2 more sources

Tumoral calcinosis [PDF]

Journal of Inherited Metabolic Disease, 2010
Contains fulltext : 87587.pdf (Publisher’s version ) (Open Access)
de Sévaux, Ruud G. L., Janssen, Mirian C. H.   +1 more
core   +6 more sources

Familial hyperphosphatemic tumoral calcinosis: A rare case report from Syria [PDF]

Clinical Case Reports
Key Clinical Message Tumoral calcinosis is a very rare disease mainly caused by a disturbance in phosphate metabolism. It is advisable to contemplate screening more organs such as testes, thyroid, and spleen in patients with TC.
Balkis Al Abdulrahman, Hiba Eed, Rama Kurdy, Yazan Alwadi, Salwa Alcheikh   +4 more
doaj   +2 more sources

Familial tumoral calcinosis in two Chinese patients: a case series [PDF]

Journal of Medical Case Reports, 2011
Introduction Tumoral calcinosis is a rare and benign condition characterized by massive subcutaneous soft tissue deposits of calcium phosphate predominantly around large joints.
Cheng Xiaoli, Gu Jiaowei, Zhang Che, Xiong Kui   +3 more
doaj   +4 more sources

Multiple uremic tumoral calcinosis in periarticular soft tissues with chronic renal failure: a case report. [PDF]

Front Endocrinol (Lausanne), 2023
He L, Li M, Lin C, Yan K, Yang C, Tang J.   +5 more
europepmc   +3 more sources

Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome [PDF]

Journal of Bone and Mineral Research, 2016
Familial tumoral calcinosis (FTC)/hyperostosis-hyperphosphatemia syndrome (HHS) is a rare disorder caused by mutations in the genes encoding fibroblast growth factor-23 (FGF23), N-acetylgalactosaminyltransferase 3 (GALNT3), or KLOTHO.
Pravitt Gourh, Raphaela T Goldbach-Mansky, Shoji Ichikawa   +2 more
exaly   +3 more sources

Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management

Frontiers in Endocrinology, 2020
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare and disabling disorder of fibroblast growth factor 23 (FGF23) deficiency or resistance.
Rachel I Gafni
exaly   +3 more sources

Alterations in SAMD9, AHSG, FRG2C, and FGFR4 Genes in a Case of Late-Onset Massive Tumoral Calcinosis. [PDF]

AACE Clin Case Rep, 2023
Background/Objective: Tumoral calcinosis (TC) is a rare, arcane, and debilitating disorder of phosphate metabolism manifesting as hard masses in soft tissues.
Leow MKS, Ang J, Bi X, Koh ET, McFarlane C.   +4 more
europepmc   +3 more sources